Skip to Content
Merck
CN

The discovery of potent small molecule cyclic urea activators of STING.

European journal of medicinal chemistry (2022-01-09)
Sourav Basu, Sandip Middya, Monali Banerjee, Rajib Ghosh, David C Pryde, Dharmendra B Yadav, Ritesh Shrivastava, Arjun Surya
ABSTRACT

STING mediates innate immune responses that are triggered by the presence of cytosolic DNA. Activation of STING to boost antigen recognition is a therapeutic modality that is currently being tested in cancer patients using nucleic-acid based macrocyclic STING ligands. We describe here the discovery of 3,4-dihydroquinazolin-2(1H)-one based 6,6-bicyclic heterocyclic agonists of human STING that activate all known human variants of STING with high potency.

MATERIALS
Product Number
Brand
Product Description

STING agonist C53, ≥98% (HPLC)